{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:44:22Z","timestamp":1783359862190,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s13346-025-01793-0","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T13:45:06Z","timestamp":1737380706000},"page":"3119-3136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Self-assembly of multi-arm star PEG containing TXA9 into nanoparticle for the efficient chemotherapy of NSCLC"],"prefix":"10.1007","volume":"15","author":[{"given":"Qilong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haosheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"3","key":"1793_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung HYA, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA-Cancer J Clin"},{"issue":"7957","key":"1793_CR2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41586-023-05729-x","volume":"616","author":"M Al Bakir","year":"2023","unstructured":"Al Bakir M, Huebner A, Mart\u00ednez-Ruiz C, Grigoriadis K, Watkins TBK, Pich O, Moore DA, Veeriah S, Ward S, Laycock J, et al. The evolution of non-small cell lung cancer metastases in TRACERx. Nature. 2023;616(7957):534\u201342.","journal-title":"Nature"},{"key":"1793_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-018-0789-x","volume":"17","author":"M Rom\u00e1n","year":"2018","unstructured":"Rom\u00e1n M, Baraibar I, L\u00f3pez I, Nadal E, Rolfo C, Vicent S, Gil-Bazo I. KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Mol Cancer. 2018;17:14.","journal-title":"Mol Cancer"},{"issue":"6","key":"1793_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1200\/JCO.21.01589","volume":"40","author":"JE Chaft","year":"2022","unstructured":"Chaft JE, Shyr Y, Sepesi B, Forde PM. Preoperative and postoperative systemic therapy for Operable non\u2013small-cell Lung Cancer. J Clin Oncol. 2022;40(6):546\u201355.","journal-title":"J Clin Oncol"},{"key":"1793_CR5","doi-asserted-by":"crossref","unstructured":"Kanagalingam S, Ul Haq Z, Victory Srinivasan N, Khan AI, Mashat GD, Hazique M, Khan KI, Ramesh P, Khan S. Comparing Gefitinib and Traditional Chemotherapy for Better Survival in patients with Non-small Cell Lung Cancer: a systematic review. Cureus; 2023.","DOI":"10.7759\/cureus.33691"},{"issue":"10","key":"1793_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41571-023-00794-7","volume":"20","author":"G Mountzios","year":"2023","unstructured":"Mountzios G, Remon J, Hendriks LEL, Garc\u00eda-Campelo R, Rolfo C, Van Schil P, Forde PM, Besse B, Subbiah V, Reck M, et al. Immune-checkpoint inhibition for resectable non-small-cell lung cancer \u2014 opportunities and challenges. Nat Reviews Clin Oncol. 2023;20(10):664\u201377.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"9","key":"1793_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41571-021-00501-4","volume":"18","author":"JE Chaft","year":"2021","unstructured":"Chaft JE, Rimner A, Weder W, Azzoli CG, Kris MG, Cascone T. Evolution of systemic therapy for stages I\u2013III non-metastatic non-small-cell lung cancer. Nat Reviews Clin Oncol. 2021;18(9):547\u201357.","journal-title":"Nat Reviews Clin Oncol"},{"key":"1793_CR8","doi-asserted-by":"crossref","unstructured":"Kumar V, Yadavilli S, Kannan R. A review on RNAi therapy for NSCLC: opportunities and challenges. Wiley Interdiscip Rev -Nanomed Nanobiotechnol. 2021, 13 (2).","DOI":"10.1002\/wnan.1677"},{"key":"1793_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/molecules25163596","volume":"25","author":"D Reddy","year":"2020","unstructured":"Reddy D, Kumavath R, Barh D, Azevedo V, Ghosh P. Anticancer and Antiviral properties of Cardiac glycosides: a review to explore the mechanism of actions. Molecules. 2020;25:16.","journal-title":"Molecules"},{"key":"1793_CR10","doi-asserted-by":"crossref","unstructured":"Kim N, Yim HY, He N, Lee C-J, Kim JH, Choi J-S, Lee HS, Kim S, Jeong E, Song M et al. Cardiac glycosides display selective efficacy for STK11 mutant lung cancer. Sci Rep 2016, 6.","DOI":"10.1038\/srep29721"},{"issue":"3","key":"1793_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41416-020-01135-6","volume":"124","author":"L Yang","year":"2021","unstructured":"Yang L, Zhou F, Zhuang Y, Liu Y, Xu L, Zhao H, Xiang Y, Dai X, Liu Z, Huang X, et al. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9\/STAT3 signalling pathway. Br J Cancer. 2021;124(3):645\u201357.","journal-title":"Br J Cancer"},{"key":"1793_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.steroids.2014.12.015","volume":"94","author":"R Xue","year":"2015","unstructured":"Xue R, Han N, Xia MY, Ye C, Hao ZH, Wang LH, Wang Y, Yang JY, Saiki I, Yin J. TXA9, a cardiac glycoside from Streptocaulon juventas, exerts a potent anti-tumor activity against human non-small cell lung cancer cells in vitro and in vivo. Steroids. 2015;94:51\u20139.","journal-title":"Steroids"},{"key":"1793_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.steroids.2014.10.005","volume":"93","author":"C Ye","year":"2015","unstructured":"Ye C, Wang H, Xue R, Han N, Wang LH, Yang JY, Wang Y, Yin J. Minor cytotoxic cardenolide glycosides from the root of Streptocaulon juventas. Steroids. 2015;93:39\u201346.","journal-title":"Steroids"},{"key":"1793_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.fitote.2014.08.008","volume":"98","author":"R Xue","year":"2014","unstructured":"Xue R, Han N, Ye C, Wang LH, Yang JY, Wang Y, Yin J. The cytotoxic activities of cardiac glycosides from Streptocaulon juventas and the structure-activity relationships. Fitoterapia. 2014;98:228\u201333.","journal-title":"Fitoterapia"},{"key":"1793_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bioorg.2024.107633","volume":"151","author":"Z Liu","year":"2024","unstructured":"Liu Z, Wang QL, Chi Y, Chen R, Zhao LC, Liu ZH, Zhai JX, Li SK, Han N, Yin J. Acovenosigenin A \u03b2-glucoside mediates JAK2-STAT3 signaling pathway by targeting GP130 in A549 and H460 cells based on integrative analysis of transcriptome and proteome and biological verification. Bioorg Chem. 2024;151:13.","journal-title":"Bioorg Chem"},{"issue":"3","key":"1793_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11095-020-02789-w","volume":"37","author":"YW Li","year":"2020","unstructured":"Li YW, Ye C, Cai CC, Zhao M, Han N, Liu ZH, Zhai JX, Yin J. Design and synthesis of polymer prodrugs for improving Water-Solubility, Pharmacokinetic Behavior and Antitumor Efficacy of TXA9. Pharm Res. 2020;37(3):14.","journal-title":"Pharm Res"},{"issue":"9","key":"1793_CR17","doi-asserted-by":"publisher","first-page":"8097","DOI":"10.1021\/acssuschemeng.7b01715","volume":"5","author":"YX Liu","year":"2017","unstructured":"Liu YX, Qi Q, Li XM, Liu J, Wang LY, He J, Lei JD. Self-assembled pectin-conjugated eight-arm polyethylene glycol-dihydroartemisinin nanoparticles for Anticancer Combination Therapy. ACS Sustain Chem Eng. 2017;5(9):8097\u2013107.","journal-title":"ACS Sustain Chem Eng"},{"issue":"3","key":"1793_CR18","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1021\/acssuschemeng.8b06586","volume":"7","author":"YX Liu","year":"2019","unstructured":"Liu YX, Zong YH, Yang ZX, Luo M, Li GL, Wang YS, Cao YL, Xiao M, Kong TJ, He J, et al. Dual-targeted controlled delivery based on folic acid modified pectin-based nanoparticles for combination therapy of Liver Cancer. ACS Sustain Chem Eng. 2019;7(3):3614\u201323.","journal-title":"ACS Sustain Chem Eng"},{"key":"1793_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biomaterials.2022.121415","volume":"283","author":"M Liu","year":"2022","unstructured":"Liu M, Li J, Zhao D, Yan N, Zhang HX, Liu MY, Tang XY, Hu YW, Ding JQ, Zhang N, et al. Branched PEG-modification: a new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy. Biomaterials. 2022;283:13.","journal-title":"Biomaterials"},{"issue":"10","key":"1793_CR20","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1021\/acs.biomac.9b00842","volume":"20","author":"H Choi","year":"2019","unstructured":"Choi H, Choi W, Kim J, Kong WH, Kim KS, Kim C, Hahn SK. Multifunctional nanodroplets encapsulating naphthalocyanine and perfluorohexane for bimodal image-guided therapy. Biomacromolecules. 2019;20(10):3767\u201377.","journal-title":"Biomacromolecules"},{"key":"1793_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jconrel.2020.04.039","volume":"323","author":"XB Zhao","year":"2020","unstructured":"Zhao XB, Si JX, Huang DS, Li K, Xin Y, Sui MH. Application of star poly(ethylene glycol) derivatives in drug delivery and controlled release. J Control Release. 2020;323:565\u201377.","journal-title":"J Control Release"},{"key":"1793_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nantod.2022.101480","volume":"44","author":"YX Yang","year":"2022","unstructured":"Yang YX, Zuo SY, Zhang JX, Liu T, Li XM, Zhang HT, Cheng MS, Wang SJ, He ZG, Sun BJ, et al. Prodrug nanoassemblies bridged by Mono-\/Di-\/Tri-sulfide bonds: exploration is for going further. Nano Today. 2022;44:10.","journal-title":"Nano Today"},{"issue":"32","key":"1793_CR23","doi-asserted-by":"publisher","first-page":"11745","DOI":"10.1021\/acssuschemeng.2c07187","volume":"11","author":"YY Chen","year":"2023","unstructured":"Chen YY, Wang JT, Wang QM, Lei XJ, Zhao JC, Xu ZG, Ming J. Coordination-Bonded Fucoidan-based curcumin nanoparticle for Cancer-targeted therapy. ACS Sustain Chem Eng. 2023;11(32):11745\u201355.","journal-title":"ACS Sustain Chem Eng"},{"key":"1793_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jconrel.2024.01.029","volume":"366","author":"HZ Wang","year":"2024","unstructured":"Wang HZ, Yuan Y, Qin L, Yue MM, Xue JW, Cui ZX, Zhan XG, Gai JY, Zhang X, Guan J, et al. Tunable rigidity of PLGA shell-lipid core nanoparticles for enhanced pulmonary siRNA delivery in 2D and 3D lung cancer cell models. J Control Release. 2024;366:746\u201360.","journal-title":"J Control Release"},{"key":"1793_CR25","doi-asserted-by":"crossref","unstructured":"Hyldbakk A, Hansen T, Hak S, Borgos SE. F. Polyethylene glycol (PEG) as a broad applicability marker for LC-MS\/ MS-based biodistribution analysis of nanomedicines. J. Control. Release 2024, 366, 611\u2013620.","DOI":"10.1016\/j.jconrel.2024.01.016"},{"issue":"8","key":"1793_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/adhm.201801177","volume":"8","author":"DY Joh","year":"2019","unstructured":"Joh DY, Zimmers Z, Avlani M, Heggestad JT, Aydin HB, Ganson N, Kumar S, Fontes CM, Achar RK, Hershfield MS, et al. Architectural modification of conformal PEG-Bottlebrush Coatings minimizes Anti-PEG antigenicity while preserving Stealth Properties. Adv Healthc Mater. 2019;8(8):13.","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"1793_CR27","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1039\/C4CS00329B","volume":"44","author":"R Verduzco","year":"2015","unstructured":"Verduzco R, Li XY, Peseka SL, Steinc GE. Structure, function, self-assembly, and applications of bottlebrush copolymers. Chem Soc Rev. 2015;44(8):2405\u201320.","journal-title":"Chem Soc Rev"},{"issue":"4","key":"1793_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/rcm.7798","volume":"31","author":"PC Kooijman","year":"2017","unstructured":"Kooijman PC, Kok S, Honing M. Independent assessment of matrix-assisted laser desorption\/ionization mass spectrometry (MALDI-MS) sample preparation quality: Effect of sample preparation on MALDI-MS of synthetic polymers. Rapid Commun Mass Spectrom. 2017;31(4):362\u201370.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"9","key":"1793_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd2614","volume":"7","author":"ME Davis","year":"2008","unstructured":"Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9):771\u201382.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1793_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505\u201315.","journal-title":"Mol Pharm"},{"issue":"4","key":"1793_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1021\/mp900090z","volume":"6","author":"E Gullotti","year":"2009","unstructured":"Gullotti E, Yeo Y, Extracellularly Activated Nanocarriers. A new paradigm of Tumor targeted drug delivery. Mol Pharm. 2009;6(4):1041\u201351.","journal-title":"Mol Pharm"},{"issue":"11","key":"1793_CR32","first-page":"13","volume":"9","author":"M Li","year":"2014","unstructured":"Li M, Liang Z, Sun X, Gong T, Zhang ZR. A polymeric prodrug of 5-Fluorouracil-1-Acetic acid using a Multi-hydroxyl Polyethylene Glycol Derivative as the drug carrier. PLoS ONE. 2014;9(11):13.","journal-title":"PLoS ONE"},{"issue":"48","key":"1793_CR33","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.1002\/adma.201603095","volume":"28","author":"N Qiu","year":"2016","unstructured":"Qiu N, Liu X, Zhong Y, Zhou Z, Piao Y, Miao L, Zhang Q, Tang J, Huang L, Shen Y. Esterase-activated charge-reversal polymer for fibroblast-exempt Cancer Gene Therapy. Adv Mater. 2016;28(48):10613\u2013.","journal-title":"Adv Mater"},{"issue":"18","key":"1793_CR34","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1039\/C5TB00042D","volume":"3","author":"L Dai","year":"2015","unstructured":"Dai L, Cao X, Liu K-F, Li C-X, Zhang G-F, Deng L-H, Si C-L, He J, Lei J-D. Self-assembled targeted folate-conjugated eight-arm-polyethylene glycol-betulinic acid nanoparticles for co-delivery of anticancer drugs. J Mat Chem B. 2015;3(18):3754\u201366.","journal-title":"J Mat Chem B"},{"key":"1793_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.msec.2017.12.018","volume":"86","author":"YX Liu","year":"2018","unstructured":"Liu YX, Liu KF, Li XM, Xiao SZ, Zheng D, Zhu PB, Li CX, Liu J, He J, Lei JD, et al. A novel self-assembled nanoparticle platform based on pectin-eight-arm polyethylene glycol-drug conjugates for co-delivery of anticancer drugs. Mater Sci Eng C-Mater Biol Appl. 2018;86:28\u201341.","journal-title":"Mater Sci Eng C-Mater Biol Appl"},{"key":"1793_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41467-019-11193-x","volume":"10","author":"BJ Sun","year":"2019","unstructured":"Sun BJ, Luo C, Zhang XB, Guo MR, Sun MC, Yu H, Chen Q, Yang WQ, Wang ML, Zuo SY, et al. Probing the impact of sulfur\/selenium\/carbon linkages on prodrug nanoassemblies for cancer therapy. Nat Commun. 2019;10:10.","journal-title":"Nat Commun"},{"issue":"5","key":"1793_CR37","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1039\/c3nr05559k","volume":"6","author":"D Pozzi","year":"2014","unstructured":"Pozzi D, Colapicchioni V, Caracciolo G, Piovesana S, Capriotti AL, Palchetti S, De Grossi S, Riccioli A, Amenitsch H, Lagan\u00e0 A. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale. 2014;6(5):2782\u201392.","journal-title":"Nanoscale"},{"issue":"8\u20139","key":"1793_CR38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.progpolymsci.2007.05.008","volume":"32","author":"G Pasut","year":"2007","unstructured":"Pasut G, Veronese FM. Polymer-drug conjugation, recent achievements and general strategies. Prog Polym Sci. 2007;32(8\u20139):933\u201361.","journal-title":"Prog Polym Sci"},{"key":"1793_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.colsurfa.2023.132823","volume":"682","author":"MC Zheng","year":"2024","unstructured":"Zheng MC, Mei T, Deng CT, Xin JQ, Aras O, An FF, Chen ND. The impact of PEG chain length on the in vivo tumor accumulation of self-assembled amphiphilic drug-PEG polymeric micelles. Colloid Surf A-Physicochem Eng Asp. 2024;682:9.","journal-title":"Colloid Surf A-Physicochem Eng Asp"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01793-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01793-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01793-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:41:36Z","timestamp":1757130096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01793-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1793"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01793-0","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"6 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Animal Ethics Committee of Shenyang Pharmaceutical University (approval number: SYPU-IACUC-S2023-0710-101). All animal procedures conformed to the NIH Guide for Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable. No human studies have been performed in this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}